Medtronic Inc. (MDT): Today's Featured Health Services Winner

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

Medtronic ( MDT) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.5%. By the end of trading, Medtronic rose 50 cents (1.2%) to $43.16 on heavy volume. Throughout the day, 6.7 million shares of Medtronic exchanged hands as compared to its average daily volume of 4.5 million shares. The stock ranged in a price between $42.39-$43.48 after having opened the day at $42.52 as compared to the previous trading day's close of $42.66. Other companies within the Health Services industry that increased today were: Medical Action Industries ( MDCI), up 25.7%, Epocrates ( EPOC), up 21.4%, Biolase ( BIOL), up 18.5%, and CombiMatrix Corporation ( CBMX), up 15.2%.
  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Medtronic, Inc. manufactures and sells device-based medical therapies worldwide. Medtronic has a market cap of $42.95 billion and is part of the health care sector. The company has a P/E ratio of 13.7, below the S&P 500 P/E ratio of 17.7. Shares are up 3.5% year to date as of the close of trading on Friday. Currently there are 11 analysts that rate Medtronic a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates Medtronic as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, attractive valuation levels, increase in stock price during the past year, expanding profit margins and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, Urologix ( ULGX), down 9.2%, ZELTIQ Aesthetics ( ZLTQ), down 8%, Bovie Medical Corporation ( BVX), down 6.2%, and Arrhythmia Research Technology ( HRT), down 5.7%, were all laggards within the health services industry with DaVita HealthCare Partners ( DVA) being today's health services industry laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

HOLIDAY SPECIAL: Let Jim Cramer show you every trade he is making in his $2.5 Million portfolio. Join now for 14-days FREE. Sign up today to get e-mail alerts before every trade.
null

If you liked this article you might like

Medtronic Looks Vulnerable to a Bigger Decline

FDA Approves Abbott Heart Device, Stock Rises

Measure the Meaning of This Rally: Cramer's 'Mad Money' Recap (Tues 8/22/17)

The 10 Stocks America's Biggest Hedge Funds Are Dumping Like Crazy

Cramer: This Rally Isn't Without Meaning